KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Qorvo (QRVO) Asset Writedowns and Impairment (2018 - 2025)

Qorvo filings provide 7 years of Asset Writedowns and Impairment readings, the most recent being -$106.6 million for Q1 2025.

On a quarterly basis, Asset Writedowns and Impairment changed N/A to -$106.6 million in Q1 2025 year-over-year; TTM through Dec 2025 was -$106.6 million, a 155.49% decrease, with the full-year FY2025 number at $6.5 million, down 97.07% from a year prior.
Asset Writedowns and Impairment hit -$106.6 million in Q1 2025 for Qorvo, down from $113.1 million in the prior quarter.
In the past five years, Asset Writedowns and Impairment ranged from a high of $113.1 million in Q3 2024 to a low of -$106.6 million in Q1 2025.
Median Asset Writedowns and Impairment over the past 4 years was $25.5 million (2022), compared with a mean of $22.7 million.